Click here to get full coverage on (CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily

(CRDL) Optimized Trading Opportunities (CRDL:CA)  Stock Traders Daily

(CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily

Click here to get full coverage on CRDL instrument inspiring smiles for memory care patients - WSFA

CRDL instrument inspiring smiles for memory care patients  WSFA

CRDL instrument inspiring smiles for memory care patients - WSFA

Click here to get full coverage on Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen  Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan

Click here to get full coverage on Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance

Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long  Yahoo Finance

Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance

Click here to get full coverage on Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - TMX Newsfile

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million  TMX Newsfile

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - TMX Newsfile

Click here to get full coverage on Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8% - Time to Sell? - MarketBeat

Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8% - Time to Sell?  MarketBeat

Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8% - Time to Sell? - MarketBeat

Click here to get full coverage on Canadian Investment Regulatory Organization Trade Resumption - CRDL - Investing News Network

Canadian Investment Regulatory Organization Trade Resumption - CRDL  Investing News Network

Canadian Investment Regulatory Organization Trade Resumption - CRDL - Investing News Network

Click here to get full coverage on CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus

CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C  GuruFocus

CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus

Click here to get full coverage on Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights - Benzinga Japan

Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights  Benzinga Japan

Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights - Benzinga Japan

Click here to get full coverage on CRDL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

CRDL Earning Date, Earning Analysis and Earning Prediction  Intellectia AI

CRDL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Click here to get full coverage on Cardiol Therapeutics (NASDAQ: CRDL) extends cash runway to Q3 2027 after $11.4M financing - Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) extends cash runway to Q3 2027 after $11.4M financing  Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) extends cash runway to Q3 2027 after $11.4M financing - Stock Titan

Click here to get full coverage on Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Investing News Network

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference  Investing News Network

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Investing News Network

Click here to get full coverage on Cardiol Therapeutics (NASDAQ: CRDL) posts Phase II ARCHER myocarditis recovery data - Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) posts Phase II ARCHER myocarditis recovery data  Stock Titan

Cardiol Therapeutics (NASDAQ: CRDL) posts Phase II ARCHER myocarditis recovery data - Stock Titan

Click here to get full coverage on Cardiol (NASDAQ: CRDL) receives U.S. patent allowance for CardiolRx, CRD-38 to 2040 - Stock Titan

Cardiol (NASDAQ: CRDL) receives U.S. patent allowance for CardiolRx, CRD-38 to 2040  Stock Titan

Cardiol (NASDAQ: CRDL) receives U.S. patent allowance for CardiolRx, CRD-38 to 2040 - Stock Titan

Click here to get full coverage on (CRDL) Stock Analysis and Trading Signals (CRDL:CA) - Stock Traders Daily

(CRDL) Stock Analysis and Trading Signals (CRDL:CA)  Stock Traders Daily

(CRDL) Stock Analysis and Trading Signals (CRDL:CA) - Stock Traders Daily

Click here to get full coverage on Heart inflammation trial reaches halfway mark in testing oral therapy - Stock Titan

Heart inflammation trial reaches halfway mark in testing oral therapy  Stock Titan

Heart inflammation trial reaches halfway mark in testing oral therapy - Stock Titan

Click here to get full coverage on Cardiol falls after mid-stage data for heart disease treatment - Seeking Alpha

Cardiol falls after mid-stage data for heart disease treatment  Seeking Alpha

Cardiol falls after mid-stage data for heart disease treatment - Seeking Alpha

Click here to get full coverage on CRDL Forecast — Price Prediction for 2026. Should I Buy CRDL? - Intellectia AI

CRDL Forecast — Price Prediction for 2026. Should I Buy CRDL?  Intellectia AI

CRDL Forecast — Price Prediction for 2026. Should I Buy CRDL? - Intellectia AI

Click here to get full coverage on Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - TMX Newsfile

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million  TMX Newsfile

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - TMX Newsfile

Click here to get full coverage on Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - TMX Newsfile

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure  TMX Newsfile

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - TMX Newsfile

Click here to get full coverage on Is It Time To Consider Buying Cordel Group Plc (LON:CRDL)? - Yahoo Finance

Is It Time To Consider Buying Cordel Group Plc (LON:CRDL)?  Yahoo Finance

Is It Time To Consider Buying Cordel Group Plc (LON:CRDL)? - Yahoo Finance

Click here to get full coverage on Earnings Miss: Is CRDL stock showing strong momentum - 2026 Update & Long-Term Capital Growth Ideas - baoquankhu1.vn

Earnings Miss: Is CRDL stock showing strong momentum - 2026 Update & Long-Term Capital Growth Ideas  baoquankhu1.vn

Earnings Miss: Is CRDL stock showing strong momentum - 2026 Update & Long-Term Capital Growth Ideas - baoquankhu1.vn

Click here to get full coverage on Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely? - simplywall.st

Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?  simplywall.st

Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely? - simplywall.st

Click here to get full coverage on Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Investing News Network

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis  Investing News Network

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Investing News Network

Click here to get full coverage on Cardiol Therapeutics announces $13.5 million private placement - Investing.com

Cardiol Therapeutics announces $13.5 million private placement  Investing.com

Cardiol Therapeutics announces $13.5 million private placement - Investing.com

Click here to get full coverage on Cordel Group Plc (LON:CRDL): When Will It Breakeven? - simplywall.st

Cordel Group Plc (LON:CRDL): When Will It Breakeven?  simplywall.st

Cordel Group Plc (LON:CRDL): When Will It Breakeven? - simplywall.st

Click here to get full coverage on CRDL Stock Price, News & Analysis - Stock Titan

CRDL Stock Price, News & Analysis  Stock Titan

CRDL Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate - Yahoo Finance

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate  Yahoo Finance

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate - Yahoo Finance

Click here to get full coverage on Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial - Investing.com

Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial  Investing.com

Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial - Investing.com

Click here to get full coverage on Cardiol Therapeutics reports positive Phase II myocarditis trial results - Investing.com

Cardiol Therapeutics reports positive Phase II myocarditis trial results  Investing.com

Cardiol Therapeutics reports positive Phase II myocarditis trial results - Investing.com

Click here to get full coverage on Should you sell your Cardiol Therapeutics stock? - Cantech Letter

Should you sell your Cardiol Therapeutics stock?  Cantech Letter

Should you sell your Cardiol Therapeutics stock? - Cantech Letter

Click here to get full coverage on Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference - TipRanks

Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference  TipRanks

Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference - TipRanks

Click here to get full coverage on Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? - Nasdaq

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?  Nasdaq

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? - Nasdaq

Click here to get full coverage on Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - The Globe and Mail

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?  The Globe and Mail

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - The Globe and Mail

Click here to get full coverage on Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs - TipRanks

Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs  TipRanks

Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs - TipRanks

Click here to get full coverage on Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses - TipRanks

Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses  TipRanks

Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses - TipRanks

Click here to get full coverage on Is Cardiol Therapeutics a buy? - Cantech Letter

Is Cardiol Therapeutics a buy?  Cantech Letter

Is Cardiol Therapeutics a buy? - Cantech Letter

Click here to get full coverage on Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs - TipRanks

Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs  TipRanks

Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs - TipRanks

Click here to get full coverage on Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing - TipRanks

Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing  TipRanks

Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing - TipRanks

Click here to get full coverage on Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Canada

Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com  Investing.com Canada

Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Canada

Click here to get full coverage on RNS Hotlist with Zak Mir: SWC, STG, EEE, KEFI, HEMO, CRDL, ITX & EUA - Share Talk

RNS Hotlist with Zak Mir: SWC, STG, EEE, KEFI, HEMO, CRDL, ITX & EUA  Share Talk

RNS Hotlist with Zak Mir: SWC, STG, EEE, KEFI, HEMO, CRDL, ITX & EUA - Share Talk

Click here to get full coverage on Is Cordel Group Plc (LON:CRDL) Potentially Undervalued? - simplywall.st

Is Cordel Group Plc (LON:CRDL) Potentially Undervalued?  simplywall.st

Is Cordel Group Plc (LON:CRDL) Potentially Undervalued? - simplywall.st

Click here to get full coverage on CRDL - Cardiol Therapeu Latest Stock News & Market Updates - Stock Titan

CRDL - Cardiol Therapeu Latest Stock News & Market Updates  Stock Titan

CRDL - Cardiol Therapeu Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Cardiol Therapeutics (CRDL) - Zacks Investment Research

Cardiol Therapeutics (CRDL)  Zacks Investment Research

Cardiol Therapeutics (CRDL) - Zacks Investment Research

Click here to get full coverage on Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - TMX Newsfile

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders  TMX Newsfile

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - TMX Newsfile

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL) - Seeking Alpha

Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL)  Seeking Alpha

Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL) - Seeking Alpha

Click here to get full coverage on Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com

Cardiol Therapeutics announces $13.5 million bought deal financing  Investing.com

Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com

Click here to get full coverage on Cardiol Therapeutics (CRDL) Upgraded to Buy: Here's Why - Yahoo Finance

Cardiol Therapeutics (CRDL) Upgraded to Buy: Here's Why  Yahoo Finance

Cardiol Therapeutics (CRDL) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Thunder on the track: CRDL’s grand final and your chance to join the action - HerCanberra

Thunder on the track: CRDL’s grand final and your chance to join the action  HerCanberra

Thunder on the track: CRDL’s grand final and your chance to join the action - HerCanberra

Click here to get full coverage on CRDL Forecast — Price Target — Prediction for 2027 - TradingView

CRDL Forecast — Price Target — Prediction for 2027  TradingView

CRDL Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Cardiol Therapeutics Announces Year-End 2024 Update on Operations - Yahoo Finance

Cardiol Therapeutics Announces Year-End 2024 Update on Operations  Yahoo Finance

Cardiol Therapeutics Announces Year-End 2024 Update on Operations - Yahoo Finance

Click here to get full coverage on A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics - thedeepdive.ca

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics  thedeepdive.ca

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics - thedeepdive.ca

Click here to get full coverage on Here's Why You May Invest in Cardiol Therapeutics (CRDL) Stock - Nasdaq

Here's Why You May Invest in Cardiol Therapeutics (CRDL) Stock  Nasdaq

Here's Why You May Invest in Cardiol Therapeutics (CRDL) Stock - Nasdaq

Click here to get full coverage on Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol "CRDL" - Yahoo Finance

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol "CRDL"  Yahoo Finance

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol "CRDL" - Yahoo Finance

Click here to get full coverage on Cardiol Therapeutics Announces Year-End 2023 Update on Operations - Stock Titan

Cardiol Therapeutics Announces Year-End 2023 Update on Operations  Stock Titan

Cardiol Therapeutics Announces Year-End 2023 Update on Operations - Stock Titan

Click here to get full coverage on Cardiol Therapeutics (CRDL) Stock Forecast and Price Target 2026 $CRDL - MarketBeat

Cardiol Therapeutics (CRDL) Stock Forecast and Price Target 2026 $CRDL  MarketBeat

Cardiol Therapeutics (CRDL) Stock Forecast and Price Target 2026 $CRDL - MarketBeat

Click here to get full coverage on How a rare instrument is helping a Virginia senior living facility - WUSA9

How a rare instrument is helping a Virginia senior living facility  WUSA9

How a rare instrument is helping a Virginia senior living facility - WUSA9

Click here to get full coverage on Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT - Stock Titan

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT  Stock Titan

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT - Stock Titan

Click here to get full coverage on 5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era - Yahoo Finance

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era  Yahoo Finance

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era - Yahoo Finance

Click here to get full coverage on Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease (NASDAQ:CRDL) - Seeking Alpha

Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease (NASDAQ:CRDL)  Seeking Alpha

Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease (NASDAQ:CRDL) - Seeking Alpha

Click here to get full coverage on Cardiol Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (CRDL) - The Globe and Mail

Cardiol Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (CRDL)  The Globe and Mail

Cardiol Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (CRDL) - The Globe and Mail

Click here to get full coverage on Breakthrough Heart Disease Treatments by Cardiol Therapeutics - Investing News Network

Breakthrough Heart Disease Treatments by Cardiol Therapeutics  Investing News Network

Breakthrough Heart Disease Treatments by Cardiol Therapeutics - Investing News Network

Click here to get full coverage on Cardiol Therapeutics (CRDL) Earnings Date and Reports 2026 $CRDL - MarketBeat

Cardiol Therapeutics (CRDL) Earnings Date and Reports 2026 $CRDL  MarketBeat

Cardiol Therapeutics (CRDL) Earnings Date and Reports 2026 $CRDL - MarketBeat

Click here to get full coverage on Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL) - FinancialContent

Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)  FinancialContent

Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL) - FinancialContent

Click here to get full coverage on Cardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart disease - Proactive financial news

Cardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart disease  Proactive financial news

Cardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart disease - Proactive financial news

Click here to get full coverage on Cardiol Therapeutics (CRDL) Institutional Ownership 2026 $CRDL - MarketBeat

Cardiol Therapeutics (CRDL) Institutional Ownership 2026 $CRDL  MarketBeat

CRDL

Price Chart

Key Statistics

Technicals

About CRDL

Latest News

(CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily

CRDL instrument inspiring smiles for memory care patients - WSFA

Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan

Advanced Charts

Top Gainers

Top Losers